---

DNA Damage and Cellular Stress Responses

Ubiquitination of p53 at Multiple Sites in the DNA-Binding Domain

Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong

^* To whom correspondence should be addressed. E-mail: bcrandy{at}ust.hk.

	Abstract

The tumor suppressor p53 is negatively regulated by the ubiquitin ligase MDM2. The MDM2 recognition site is at the NH₂-terminal region of p53, but the positions of the actual ubiquitination acceptor sites are less well defined. Lysine residues at the COOH-terminal region of p53 are implicated as sites for ubiquitination and other post-translational modifications. Unexpectedly, we found that substitution of the COOH-terminal lysine residues did not diminish MDM2-mediated ubiquitination. Ubiquitination was not abolished even after the entire COOH-terminal regulatory region was removed. Using a method involving in vitro proteolytic cleavage at specific sites after ubiquitination, we found that p53 was ubiquitinated at the NH₂-terminal portion of the protein. The lysine residue within the transactivation domain is probably not essential for ubiquitination, as substitution with an arginine did not affect MDM2 binding or ubiquitination. In contrast, several conserved lysine residues in the DNA-binding domain are critical for p53 ubiquitination. Removal of the DNA-binding domain reduced ubiquitination and increased the stability of p53. These data provide evidence that in addition to the COOH-terminal residues, p53 may also be ubiquitinated at sites in the DNA-binding domain. (Mol Cancer Res 2006;4(1):1-11)

Key Words: MDM2, p53, proteolysis, tumor suppressor, ubiquitin

This article has been cited by other articles:

				L. Nie, M. Sasaki, and C. G. Maki Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination J. Biol. Chem., May 11, 2007; 282(19): 14616 - 14625. [Abstract] [Full Text] [PDF]

				W. M. Chan and R. Y.C. Poon The p53 Isoform {Delta}p53 Lacks Intrinsic Transcriptional Activity and Reveals the Critical Role of Nuclear Import in Dominant-Negative Activity Cancer Res., March 1, 2007; 67(5): 1959 - 1969. [Abstract] [Full Text] [PDF]